Kardigan, a heart health company modernizing cardiovascular drug development, announced positive Phase 2 data on ataciguat in patients with moderate calcific aortic valve stenosis, presented today in ...

COPENHAGEN, Denmark—Among patients with severe aortic stenosis at low- or intermediate-risk for surgery who also have very calcified aortic valves, SAVR is associated with lower risks of all-cause ...

It’s the height of meeting season! All our most-read stories this month hailed from the news team’s on-site coverage.

CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating ...

CMS issued a final National Coverage Determination (NCD) that green-lights renal denervation (RDN) for uncontrolled ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

Anteris or the Company ) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart ...

Cardiologist Dr. Pradip Jamnadas has revealed that poor oral hygiene may predict heart disease, as harmful mouth bacteria can ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...

Abbott reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR) system.

Heart attack despite a healthy diet? Stroke without high blood pressure? The reason might lie in the blood—and few people know about it. Lipoprotein(a) is a value that is genetically determined and ...

Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...